Degraders that target ALK and therapeutic uses thereof
US12233128B2 · kind B2 · utility
0Cited by
0References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 26, 2019 |
| Grant date | Feb 25, 2025 |
| Priority date | — |
| Expiry date | May 25, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D498/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are bispecific compounds (degraders) that target ALK for degradation. Also disclosed are pharmaceutical compositions containing the degraders and methods of using the compounds to treat diseases and disorders characterized or mediated by aberrant ALK activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.